Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Metals One

    MCap

    GBP2m

    Last close

    GBP0.01

    ▲ 0.15 (37.50%)

    OpGen

    MCap

    USD16m

    Last close

    USD1.88

    ▲ 0.40 (26.60%)

    Chosa

    MCap

    SEK48m

    Last close

    SEK0.67

    ▲ 0.10 (17.54%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Edison Growth Conference panel – 2024: The year of M&A?

Edison Growth Conference panel – 2024: The year of M&A?

BB Biotech — 6 videos in collection

Mutares — 7 videos in collection

More on this equity

The second panel at the inaugural Edison Growth Conference 2024 was titled ‘2024 – the year of M&A?’ After a two-year bear market, where global M&A dropped from $5tn in 2021 to $2.5tn in 2023, we are seeing signs of a recovery. M&A activity is being driven by a more stable financing environment, pent up demand and strategic requirements to shift business models to meet the mega-trend challenges and opportunities from areas such as AI and decarbonisation. The panel shared how they capitalise on these opportunities in different ways, from BB Biotech in Healthcare, to Mutares, which focuses on turnarounds, to Oakley Capital, a listed PE firm operating in the consumer, technology and education sectors.

Watch the recording of the discussion moderated by Edison’s Neil Shah and featuring:

• Ivo Hobson, head of UK, Mutares (XETR:MUX)
• Claude Mikkelsen, director of investor relations, BB Biotech (SW:SIX)
• James Isola, head of communications, Oakley Capital (LSE:OCI)

< Previous
Next >

You may also be interested in these:

Investment Companies

BB Biotech – executive interview

Investment Companies

BB Biotech – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free